ANRO Stock Analysis: Buy, Sell, or Hold?
ANRO - Alto Neuroscience Inc.
$24.44
1.51 (6.59%)
▲
5d:
+15.45%
30d:
+13.46%
90d:
+22.08%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When ANRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ANRO is 9.5% above its trading range ($22.31). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ANRO is 9.5% above its trading range ($22.31). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ANRO is currently trading at $24.44, which is considered extended relative to its 30-day fair value range of $19.40 to $22.31.
Technical Outlook: Technically, ANRO is in a uptrend. Immediate support is located at $17.97, while resistance sits at $25.80. The stock is showing strong short-term momentum, up 6.6% recently.
Market Sentiment: ANRO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $35.13 (+43.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ANRO is in a uptrend. Immediate support is located at $17.97, while resistance sits at $25.80. The stock is showing strong short-term momentum, up 6.6% recently.
Market Sentiment: ANRO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $35.13 (+43.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.40 -
$22.31
Company Quality Score
61/100
(BUY)
Options IV Signal
45th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
64.6%
All Signals
- BEARISH: Price extended above range (+9.5% above its trading range)
- NEUTRAL: Options fairly priced (IV 45th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.6%)
- BULLISH: Trading 43.7% below Wall St target ($35.13)
- CAUTION: Extended 9.5% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$19.40 -
$22.31
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.64
(14.9%)
Support & Resistance Levels
Support Level
$17.97
Resistance Level
$25.80
Current Trend
Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.25
Wall Street Target
$35.13
(+43.7%)
Share & Embed Analysis
Last updated: June 23, 2026 6:29 PM ET
Data refreshes hourly during market hours. Next update: 7:29 PM
Data refreshes hourly during market hours. Next update: 7:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANRO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
